Pulmonary Hypertension and Indicators of Right Ventricular Function

Area of Science:

• Cardiology
• Pulmonary Medicine
• Medical Imaging

Background:

• Pulmonary hypertension (PH) is a rare disease with poorly understood mechanisms.
• PH causes pulmonary arterial vasoconstriction, vessel wall thickening, and right ventricular dysfunction.
• Current diagnostic and assessment guidelines for PH are limited.

Purpose of the Study:

• To investigate the role of energetic metabolism abnormalities in PH.
• To explore the correlation between (18)F-FDG uptake and cardiac/hemodynamic parameters in PH.

Main Methods:

• Utilized positron emission tomography/computed tomography (PET/CT) with (18)F-fluorodeoxyglucose ((18)F-FDG).
• Assessed cardiac repercussions using echocardiography and cardiac catheterization.
• Analyzed energetic metabolism shift from free fatty acids to glucose in the myocardium.

Main Results:

• Observed increased (18)F-FDG uptake in PH patients, indicating a shift towards glucose metabolism.
• (18)F-FDG uptake demonstrated correlation with echocardiographic and hemodynamic parameters.
• Right ventricular dysfunction and cardiac hypertrophy were noted as repercussions of PH.

Conclusions:

• Altered myocardial energy metabolism, with increased glucose utilization, is a feature of PH.
• (18)F-FDG PET/CT may serve as a valuable tool to assess disease severity and cardiac involvement in PH.
• Further research is needed to elucidate the precise molecular pathways and therapeutic implications.